17,261 trials
Leukemia · T-cell Prolymphocytic Leukemia (T-PLL) · Cancer
Primary: Overall Response Rate (ORR) — 7.1 percentage of participants
COVID-19
Primary: Number of Participants Meeting Criteria for Each of the 8 Ordinal Scale Categories on Day 8 — 15; 21; 36; 36 Participants — p=0.927
Psoriasis · Plaque Psoriasis
Primary: Mean Percentage Change in PASI — -14.39; -20.37; -22.73; -23.49 percentage of change
HIV-1-infection
Primary: Percentage of Participants With Human Immunodeficiency Virus-1 Ribonucleic Acid (HIV-1 RNA) < 50 Copies/mL at Week 54 as Determined by the United States Food and Drug…
Chronic Lymphocytic Leukemia
Primary: Overall Response Rate (ORR) — 64.8; 69.4 percentage of participants
Healthy Volunteers · hATTR Amyloidosis
Primary: Number of Participants With at Least One Treatment-Emergent Adverse Event (TEAE) — 3; 1; 3; 7 Participants
Advanced Cancer
Primary: Objective Response Rate (ORR) Per Investigator — 20; 30; 17.4; 3.1 Percent of participants
Respiratory Syncytial Virus Infections
Primary: Percentage of Subjects With Any Solicited Local Adverse Event (AEs) [Primary Study] — 5.9; 5; 5.8; 5.9 Percentage of participants
Systemic Lupus Erythematosus
Primary: Number of Participants Achieving a Combined Clinical Response Using the Systemic Lupus Erythematosus (SLE) Responder Index (SRI) at Week 24 — 37; 31 Participants…
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Primary: Objective Response Rate (ORR) Based on Independent Reviewer Assessment — 76.5; 100.0 percentage of participants
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage IA Breast Cancer AJCC v8 · Anatomic Stage IB Breast Cancer AJCC v8
Primary: Pathologic Complete Response (pCR) Rate Defined as a Residual Tumor Burden of 0-1 in the Surgical Specimen — 0.64 proportion of participants
Status Epilepticus · Convulsive Status EPILEPTICUS · Non Convulsive Status Epilepticus
Primary: Number of Participants Who Did Not Require an IV Anesthetic Drug for SE Treatment — 5; 4; 8 Participants
Mantle Cell Lymphoma (MCL)
Primary: Complete Response — 3; 1; 2; 1 Participants
Alcoholic Hepatitis
Primary: Lille Model for Alcoholic Hepatitis Score — 0.020; 0.050; 0.155; 0.195 score on a scale
Blepharitis
Primary: Percentage of Study Eyes With Complete Cure (Score 0) of Blepharitis Signs and Symptoms at Day 15 — 4; 2 study eyes — p=0.4434